Arexvy

GSK's Arexvy RSV Shot Tops Pfizer in Sales Race

GSK’s Arexvy Vaccine Poised for Blockbuster Sales, Besting Pfizer in RSV Market Debut

Anika Sharma

Pfizer is facing not only a decline in its COVID-19 vaccine sales but also stiff competition from GSK in the ...

GSK’s RSV vaccine eyes label expansion | Pharmtales

GSK’s RSV vaccine poised for label expansion after trial success

Anika Sharma

Five months after GSK made history by securing FDA approval for its respiratory syncytial virus (RSV) vaccine, Arexvy, the company ...

Pfizer's Abrysvo Secures CDC Endorsement for Infant Protection, Intensifying RSV Vaccine Competition

Pfizer’s Abrysvo Secures CDC Endorsement for Infant Protection, Intensifying RSV Vaccine Competition

Anika Sharma

Despite GSK’s Arexvy pioneering the respiratory syncytial virus (RSV) vaccine landscape earlier this summer, Pfizer has persistently challenged the competition ...

GSK, RSV, Arexvy, awareness campaigns, Magic Johnson,

GSK Teams Up With Ex-Basketball Star To Raise Awareness Of RSV, A Deadly Virus For Babies

Anika Sharma

GSK is intensifying its campaign to raise awareness about respiratory syncytial virus (RSV) and promote its RSV vaccine, Arexvy. The ...

Pfizer, Abrysvo, Maternal RSV Vaccine, RSV, GSK, Beyfortus, Arexvy

Pfizer’s Abrysvo Achieves Landmark as First Maternal RSV Vaccine to Safeguard Newborns

Anika Sharma

Pfizer’s Abrysvo has achieved a groundbreaking milestone by becoming the first vaccine to safeguard newborns against respiratory syncytial virus (RSV) ...

GSK, Pfizer, Arexvy, RSV, Pharma, FDA, Sanofi, Moderna

GSK’s Arexvy Takes Lead in RSV Vaccine Race, Now Accessible at Leading US Pharmacies

Anika Sharma

In the competitive landscape of the respiratory syncytial virus (RSV) vaccine market, GlaxoSmithKline (GSK) stands out with its well-timed strides. ...

Arexvy: GSK Cuts RSV Hopes, Boosts 2023 Outlook

GSK lowers short-term hopes for RSV treatment Arexvy but raises 2023 forecast

SG Tylor

Great expectations surround GSK’s entry into the respiratory syncytial virus (RSV) vaccine market with their upcoming shot, Arexvy, set to ...

RSV Prevention: GSK and Moderna Lead the Way

GSK’s Arexvy and Moderna’s mRNA-1345 to lead the race for RSV prevention

SG Tylor

The respiratory syncytial virus (RSV) is a common cause of respiratory infections, especially in infants and older adults. It can ...

The first respiratory syncytial virus (RSV) vaccine for elderly people, GSK's Arexvy, received approval from the Medicines and Healthcare Products Regulatory Agency

The first respiratory syncytial virus (RSV) vaccine for elderly people, GSK’s Arexvy, received approval from the Medicines and Healthcare Products Regulatory Agency

SG Tylor

Source – GSK GSK has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted ...